Find and Pitch Jounalists, Get Your Story Covered

Tags: adipocyte, cell biology, cell culture, oxygen consumption cancer, cell biology, cell cannibalism, developmental biology, entosis cell biology, mouse brain, neuroscience, single-cell RNA sequencing, spatial transcriptomics memory kidney cells

	Profile	Recent Articles on Subject
1	Emily Cooke Live Science Health reporter. London, United Kingdom healthscience	People with this rare genetic condition can't repair damage to their DNA - 17 days ago
2	John Gever MedPage Today MedPage Today factotum. Pittsburgh, Pa. Healthcare journalism	Lupus Patients See More Vascular Risk, but It's Modifiable - about 2 months ago Stem Cell Selection Unneeded for SSc Transplant Therapy? - 3 months ago
3	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	How Social Determinants of Health Are Linked to Outcomes in Multiple Myeloma - about 2 months ago
4	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Transitioning From Pediatric to Adult Care for Beta-Thalassemia - about 2 months ago Stem Cell Transplantation Still the Main Treatment Option for Beta-Thalassemia - about 2 months ago Lovo-Cel 'Life-Changing, Transformative' in Sickle Cell Disease - about 1 year ago Potential Cure for Sickle Cell Clears Hurdle for Approval - over 1 year ago FDA Reviewers Question Safety of Sickle Cell Gene Therapy - over 1 year ago
5	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	ASH 2024 Recap: Movement in Multiple Myeloma, Cell Therapy, Sickle Cell Disease & More - 2 months ago Beam’s Base-Editing Sickle Cell Therapy Shows Early Promise, But a Fatality Overshadows Results - 4 months ago
6	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	STAT+: Biotech companies detail emerging efforts to ease ‘conditioning’ before genetic treatments - 3 months ago Sanofi advances a drug for a rare, platelet-destroying disease - 3 months ago STAT+: Patient dies in Beam Therapeutics trial of CRISPR sickle cell treatment - 4 months ago Listen: More tumult at BIO & coercive care for sickle cell patients - 9 months ago STAT+: After sickle-cell screwups, Bluebird Bio’s only option might be a company sale - about 1 year ago In historic decision, FDA approves a CRISPR-based medicine for treatment of sickle cell disease - about 1 year ago STAT+: FDA has some safety concerns about CRISPR-based sickle cell treatment, documents show - over 1 year ago
7	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	STAT+: Pfizer’s abrupt withdrawal of sickle cell drug Oxbryta called ‘tone deaf’ at ASH conference - 3 months ago
8	Jonathan Wosen STAT News West Coast Biotech Reporter. Formerly @sdut. Stanford PhD. UCSC alum. San Diego, California BiotechLife SciencesImmunology	Sanofi advances a drug for a rare, platelet-destroying disease - 3 months ago STAT+: Bone marrow transplant advance could widen use of this less buzzy cure for sickle cell disease - about 1 year ago STAT+: Historic approval of sickle cell gene therapies met with cautious optimism by experts at ASH - about 1 year ago
9	Emily Mullin Wired Staff writer at WIRED. Covers biotechnology. Fall 2021 fellow. Pittsburgh, Pennsylvania biotechnology	The First Crispr Treatment Is Making Its Way to Patients - 3 months ago The First Crispr Medicine Is Now Approved in the US - about 1 year ago The First Crispr Medicine Just Got Approved - over 1 year ago
10	Theresa Gaffney STAT News Audio producer, health reporter. Boston audio productionhealth reporting	A STAT Investigation: Pain, loss, and coercive care - 3 months ago STAT Morning Rounds: Six health news stories you need to start your day - about 1 year ago

Journalists covering sickle cell disease